Name | perphenazine |
Synonyms | perphenazine 1-Piperazineethanol, 4-[3-(2-Chlorophenothiazin-10-yl)propyl]- 1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina 1',1-(2-idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina 2-(4-(3-(2-chlorophenothiazin-10-yl)propyl)piperazin-1-yl)ethanol 1-Piperazineethanol, 4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]- 1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine 2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine 2-chloro-10-[3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl]phenothiazine 2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol |
CAS | 58-39-9 |
EINECS | 200-381-5 |
InChI | InChI=1/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2 |
Molecular Formula | C21H26ClN3OS |
Molar Mass | 403.97 |
Density | 1.253 |
Melting Point | 95-98?C |
Boling Point | bp0.15 214-218°; bp1 278-281° |
Water Solubility | 28.28mg/L(24 ºC) |
Solubility | Easily soluble in chloroform, soluble in ethanol (153 mg/ml), acetone (82 mg/ml), almost insoluble in water |
Appearance | White light yellow powder |
Color | White |
Merck | 14,7183 |
pKa | pKa 7.8(H2O,t =24±1) (Uncertain) |
Storage Condition | 2-8°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
Sensitive | `sensitive` to heat and light |
Refractive Index | 1.6100 (estimate) |
MDL | MFCD00056798 |
Physical and Chemical Properties | White or off-white crystalline powder. Melting point 94-100 ℃; Boiling point -281 ℃(0.133kPa),214-218 ℃(0.02kPa). Very soluble in chloroform, soluble in ethanol (153 mg/mL), acetone (82 mg/mL), almost insoluble in water. Sensitive to light, almost odorless, slightly bitter taste. |
Use | For the treatment of acute and chronic schizophrenia |
In vitro study | Perphenazine is a kind of phenothiazine compound that can block dopamine D2 receptor and antagonize H1, cholinoid M1 and α1 adrenergic receptor in vomiting center. Perphenazine induces cell death and mitochondrial damage, caspase-3 activation, and a decrease in intracellular ATP levels. Antioxidants inhibit perphenazine-induced cell death, whereas Pan-caspase inhibitors do not. Perphenazine at a concentration of 0.0001-0.01 μm had no significant effect on melanocyte viability. Treatment of these cells with higher concentrations of Perphenazine resulted in a concentration-dependent decrease in cell viability. The EC50 was 2.76 μm. Perphenazine at 1-3 μm also reduced tyrosinase activity and melanin content. |
In vivo study | Perphenazine is well absorbed after oral administration. The time when its concentration in the body reaches its peak is 1-3 hours after oral administration, and the peak concentration of its metabolite 7-hydroxyphenzaine appears at 2-3 hours. The elimination half-life of Perphenazine is 9-12 hours, while the half-life of its metabolite 7-hydroxyphenzaine is 10-19 hours. Perphenazine is a psychotropic drug that is used to treat certain mental illnesses. In isolated rat hearts, perphenazine significantly prolonged the QT interval, causing arrhythmias at high and therapeutic concentrations. After repeated administration, an arrhythmogenic effect can be observed. |
Hazard Symbols | Xn - Harmful |
Risk Codes | R22 - Harmful if swallowed R43 - May cause sensitization by skin contact |
Safety Description | S28 - After contact with skin, wash immediately with plenty of soap-suds. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN 2811 6.1 / PGII |
WGK Germany | 3 |
RTECS | TL7175000 |
HS Code | 29349990 |
Toxicity | LD50 oral in rat: 318mg/kg |
This product is 4-3 (2-chlorophenothiazin-10-yl) propyl]-1-piperazineethanol. The content of C21H26ClN3OS shall not be less than 98.5% calculated as dry product.
The melting point of this product (General rule 0612 first method) is 94~100°C.
take 0.20g of this product and add 0901 of methanol to dissolve, the solution should be clear and colorless; If the color is colored, it should not be deeper compared with the yellow No. 2 Standard Colorimetric solution (General rule first method).
operation in the dark. Take an appropriate amount of this product, add methanol to dissolve and dilute to prepare a solution containing lmg per lml as a test solution; Take lml for precise measurement, put it in a 100ml measuring flask, dilute it to the scale with methanol, as a control solution. According to the high performance liquid chromatography (General 0512) test, silica gel bonded with eighteen alkyl silane was used as the filler; Methanol was used as the mobile phase A, and 0.03mol/L ammonium acetate solution was used as the mobile phase B, the gradient elution was carried out according to the following table and the detection wavelength was 254nm. Take 25mg of perphenazine control, put it in a 25ml measuring flask, add 15ml of methanol to dissolve, add 2ml of 30% hydrogen peroxide solution, shake, dilute to the scale with methanol, shake well, and place it for 1.5 hours, as the system applicability solution; The system applicability solution 20u1 is injected into the liquid chromatograph, so that the retention time of perphenazine peak is about 27 minutes, and the separation degree of the degradation impurity peak with the relative retention time of about 0.73 should be greater than 7.0. 20ul of the control solution and the test solution were respectively injected into the liquid chromatograph, and the chromatograms were recorded. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than 0.5 times (0.5%) of the area of the main peak of the control solution, the sum of each impurity peak area shall not be greater than 2 times (2.0%) of the main peak area of the control solution. The chromatogram of the test solution is 0.01 times smaller than the main peak area of the control solution.
take this product, put it in a phosphorus pentoxide dryer, and dry it under reduced pressure to constant weight. The weight loss shall not exceed 0.5% (General rule 0831).
not more than 0.1% (General rule 0841).
take this product about 0.15g, precision weighing, add glacial acetic acid dissolved in 20ml, add crystal violet indicator solution 1 drop, with perchloric acid titration solution (0.lmol/L) titration to the solution is blue-green, and the titration results are corrected with a blank test, per 1 ml of perchloric acid titration solution (0.1 mol/L) corresponds to 20.20mg of C21H26C1N30S.
antipsychotics.
light shielding, sealed storage.
This product contains perphenazine (C21H26ClN3OS) should be 93.0% to 107.0% of the label.
This product is sugar-coated tablet or film-coated tablet, white or almost White after removing the coating.
operation in the dark. Take 20 tablets of this product, after removing the coating_precision weighing, fine, precision weighing an appropriate amount (about 10 mg of perphenazine), put it in a 100ml measuring flask, add solvent (take 500ml of ethanol, add 10ml hydrochloric acid, add water to 1000ml, shake well) about 70ml, fully shake to dissolve perphenazine, dilute to scale with solvent, shake well, filter, take 5ml continuous filtrate accurately, in a 100ml measuring flask, dilute to the scale with solvent, shake well, and use as a test solution, solubilization and quantitative dilution were performed to prepare a solution containing about 5ug per 1 ml as a control solution. The above two kinds of solutions were taken and the absorbance was measured at a wavelength of 255mn by ultraviolet-visible spectrophotometry (General rule 0401), and calculated.
Same as perphenazine.
(l)2mg (2)4mg
light shielding, sealed storage.
This product is a sterile aqueous solution of perphenazine. Perphenazine-containing (C21H26ClN3OS) shall be between 93.0% and 107.0% of label load.
This product is colorless to yellowish clear liquid.
take an appropriate amount of this product (about 125mg equivalent to perphenazine), put it in a separatory funnel, add 2ml of sodium hydroxide solution to make it alkaline, and extract it with chloroform shaking for 4 times, 20ml each time, the extracts were combined and filtered with dry filter paper containing 5g of anhydrous sodium sulfate. The filtrate was evaporated to dryness on a water bath and dissolved with 10ml of glacial acetic acid. 1 mol/L) titration, and the results of the titration were corrected with a blank test. Each 1 ml of perchloric acid titration solution (0.1 mol/L) corresponds to 20.20mg of C21H26ClN3OS.
perphenazine.
lml : 5mg
light shielding, closed storage.